Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Shen, X.
Right arrow Articles by Storb, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, X.
Right arrow Articles by Storb, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 11, No. 10, 1663-1671, October 1999
© 1999 Japanese Society for Immunology

The CH1 and transmembrane domains of µ in the context of a {gamma}2b transgene do not suffice to promote B cell maturation

Xuejun Shen1,3, Grazyna Bozek1, Carl A. Pinkert2 and Ursula Storb1

1 Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, IL 60637, USA
2 Department of Comparative Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-0019, USA

Correspondence to: U. Storb

Mice carrying a {gamma}2b transgene have been shown previously to be deficient in B cell development. In particular, a developmental block exists at the pre-B cell stage. The few B cells that develop all express endogenous µ heavy chains. The phenotype suggests that {gamma}2b exerts a strong feedback inhibition on endogenous Ig gene rearrangement, but, unlike µ, cannot support further B cell development. In this study we have created hybrid transgenes between {gamma}2b and µ. Transgenic mice with a CH1 domain of µ, or both a CH1 and transmembrane/cytoplasmic domain of µ replacing the respective domains of a {gamma}2b transgene, have the same B cell defect as {gamma}2b transgenic mice. Interestingly, the severity of the defect is correlated with the level of expression of the transgene, suggesting that the degree of feedback inhibition of Ig gene rearrangement depends on the level and timing of Ig production. Crossing the {gamma}2b/µ transgenes into a Bcl-xL transgenic line allows immature {gamma}2b B cells to survive, but not to develop to maturity. Therefore, the missing function of µ is not simply an anti-apoptotic effect.

Keywords: B lymphocytes, bone marrow, gene rearrangement, mRNA, transgenic mice

3 Present address: Department of Comparative Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-0019, USA

Transmitting editor: K. Knight


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.